The largest community of pharma leaders

Altasciences Welcomes Martin Poirier as Senior Director, Bioanalytical Sciences

LAVAL, Quebec–()–Altasciences is pleased to announce the appointment of Martin Poirier, M.Sc., as Senior Director of Bioanalytical Sciences, based in Altasciences’ preclinical facility in Seattle, WA. Martin will apply his extensive knowledge and experience to guide internal and external clients throughout their bioanalysis and immunomodulation analysis projects.

Martin’s outstanding industry reputation and specialization in the field of immunology, as well as more than ten years of experience managing laboratory sciences and establishing new facilities across North America, align with Altasciences’ objective of continually enhancing their full service preclinical and clinical bioanalytical capabilities. He joins the Senior Management team, and takes on responsibilities for the growth and development of Altasciences’ preclinical bioanalytical business.

We are very pleased to welcome Martin to our growing team of experts. His years of experience and breadth of knowledge will be an asset as we develop and enhance our facilities and offerings to fully and effectively support our clients’ ever-evolving needs,” said Mike Broadhurst, General Manager of Altasciences’ Seattle site.

About Altasciences

Altasciences is a forward-thinking, mid-size contract research organization offering pharmaceutical and biotechnology companies of all sizes a proven, flexible approach to preclinical and early phase clinical studies, from lead candidate selection to proof of concept. For over 25 years, Altasciences has been integrating into clients’ projects to help support educated, faster, and more complete early drug development decisions. Altasciences’ full-service solutions include preclinical safety testing, clinical pharmacology, bioanalysis, program management, medical writing, biostatistics, and data management, all of which can be tailored to specific sponsor requirements. Altasciences… helping sponsors get better drugs to the people who need them, faster.


Recent Articles